z-logo
Premium
Effect of K + channel‐modulating drugs on the vasoconstrictor responses of leukotrienes C 4 , D 4 and angiotensin II in the guinea‐pig isolated perfused heart
Author(s) -
McLeod J.D.,
Piper P.J.
Publication year - 1992
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1992.tb09048.x
Subject(s) - cromakalim , angiotensin ii , medicine , endocrinology , glibenclamide , vasodilation , bradykinin , chemistry , vascular smooth muscle , potassium channel , coronary vasodilator , biology , receptor , diabetes mellitus , smooth muscle
1 The vascular actions of leukotrienes C 4 (LTC 4 ) and LTD 4 in the guinea‐pig isolated perfused heart were studied in the presence of potassium (K + ) channel modulatory compounds. 2 Cromakalim (0.35–10 μ m ), a K + channel activator, inhibited the vasoconstrictor responses of LTC 4 (30 pmol), LTD 4 (30 pmol) and angiotensin II (AII) (100 pmol) in a concentration‐dependent manner. 3 Glyceryl trinitrate (10 mgl −1 ) and vasoactive intestinal peptide (10 n m ) induced a similar vasodilator action to cromakalim in the isolated heart but had no effect on responses to LTC 4 and LTD 4 . 4 The inhibitory action by cromakalim (10 μ m ) on the LTC 4 (30 pmol) response could be reversed in the presence of an equimolar concentration of glibenclamide. However, glibenclamide (10 μ m ) only partially restored the LTD 4 (30 pmol) actions. 5 Galanin (10 n m ) and charybdotoxin (60 n m ) had no effect on the vascular responses to LTC 4 and LTD 4 (30 pmol). 6 Inhibition by cromakalim of coronary vasospasm induced by vascular LTC 4 , LTD 4 and AII appears to be separate from its vasodilator action and it is postulated that a cromakalim‐sensitive mechanism in the coronary vasculature is important in the vasoconstrictor responses to LTC 4 , LTD 4 and AII.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom